Search
Fraunhofer Institute for Cell Therapy and Immunology IZI
Fraunhofer Institute for Cell Therapy and Immunology IZI
Jobs / career
Contact
Press / media
Sitemap
Deutsch
About us
[X]
About us
Institute in numbers
Organization structure
Locations and infrastructure
Leipzig headquarters, Saxony, Germany
Bioanalytics and Bioprocesses branch in Potsdam-Golm, Brandenburg, Germany
Department of Drug Design and Target Validation in Halle (Saale), Saxony-Anhalt, Germany
Department of Extracorporeal Therapy Systems in Rostock, Mecklenburg-Western Pomerania, Germany
Branch Lab Translational Cell Therapy in Hannover, Lower Saxony, Germany
Project Center Microelectronic and Optical Systems for Biomedicine in Erfurt, Thuringia, Germany
Research networks
Director
Advisory board
Research areas
Departments
[X]
Departments
Leipzig location
Department of GMP Cell and Gene Therapy
Department of Cell and Gene Therapy Development
Cell and Molecular Biology
NK Cell Technologies
In Vivo Models
GMP Development
GMP Biopharmaceuticals
Department of Preclinical Development and Validation
Toxicology and Immunotoxicology
Proteomics
Inflammation and Tumor Models
Department of Vaccines and Infection Models
Vaccine Technologies
Preclinical Validation
Antimicrobial Biotechnology
Department of Diagnostics
CardiOmics
Ligand Development
Experimental Imaging
MicroDiagnostics
DNA Nanodevices
Next-Generation Diagnostics
Bioinformatics
Biological Material Analytics
Halle (Saale) location
Department of Drug Design and Target Validation
Molecular Biotechnology
Protein and Drug Biochemistry
Drug Design and Analytical Chemistry
Protein Misfolding Diseases
Astacin Proteases
Rostock location
Department of Extracorporeal Therapy Systems
Potsdam-Golm location
Central facilities
[X]
Central facilities
Imaging and image evaluation
RIBOLUTION Biomarker Center
Center for Experimental Medicine
Preclinical models
GLP Test Facility
S3 safety laboratory
Press / media
[X]
Press / media
News and press releases
Development of therapeutic antibodies for HERV-associated autoimmune and tumor diseases
Hitchhiker’s Guide to the Cell: Fraunhofer IZI researches to improve imaging methods for organoids
Pathogen of Q fever detected in the feces of ticks
Professor Ulrich Demuth appointed to the German Ethics Council
Patented Fraunhofer IZI technology facilitates specific Dengue virus diagnostics
Astacin Proteases Unit established at Fraunhofer IZI
Prognostic biomarkers for prostate cancer identified
A chemical tailor-made suit for Alzheimer’s drugs
Fraunhofer relies on Automation Technologies in Medical Research
Fraunhofer IZI cooperates with Nomad Bioscience to develop novel anti-bacterial and anti-viral medications
Viromers suitable as carrier systems for gene-based treatment of inflammatory diseases
Fraunhofer IZI presents new technologies and services for the healthcare industry at the Fraunhofer Solution Days
Rapid diagnostic device for trachoma eye infection delivers first promising result
Optimization of novel immune cell therapies
SaxoCell – “living drug” Made in Saxony
Periodontitis: Researchers search for a new active substance
Fraunhofer Prize for Human- and Environment-Centered Technology 2021
Researchers aim at developing a vaccine protecting against urinary tract infection
Simplified method developed for monitoring CAR T-cell therapies using flow cytometry
Anhalt University of Applied Sciences and Fraunhofer IZI open joint research laboratory for natural product-based therapeutics
Researchers want to filter and inactivate airborne pathogens using tissue
Fraunhofer IZI and Nomad Bioscience extend and broaden collaboration
Outstanding bachelor thesis awarded
Fraunhofer opens up prospects in structurally weak regions
New Fraunhofer Center for Digital Diagnostics
Activation of the aryl hydrocarbon receptor (AhR) has an anti-inflammatory effect
Fraunhofer Center MEOS becomes technology hub for cell-based therapeutics in Thuringia
Fraunhofer IZI and BioNTech to collaborate in the future
Preclinical testing of a ATMP for the treatment of knee cartilage damage completed
Fraunhofer develops automated production technologies for mRNA-based drugs
REMEDi4ALL, an ambitious EU-funded research initiative, launches to drive forward the repurposing of medicines in Europe
Roadmap for future production of sufficient product numbers of cell-based cancer drugs
International research team elucidates molecular structure of Meprin alpha
Fraunhofer IZI implements digital Manufacturing Execution System
Hydrogels for tissue engineering
Software development expands portfolio of RIBOLUTION Biomarker Center at Fraunhofer IZI
GLP test facility of the Fraunhofer IZI certified for test category 2 since January 2023
Fraunhofer IZI contributes expertise to Germany's largest collaborative project on mosquito research
Media Library
Events
Publications
Jobs / career
Contact
[X]
Contact
How to reach us in Leipzig
How to reach us in Potsdam-Golm
How to reach us in Halle (Saale)
How to reach us in Rostock
More
© Fraunhofer IZI
© Fraunhofer IZI
Where am I?
Homepage
Central facilities
Central facilities
© Fraunhofer IZI
Imaging and image evaluation
more info
© Fraunhofer IZI
RIBOLUTION Biomarker Center
more info
© Fraunhofer IZI
Center for Experimental Medicine
more info
© Fraunhofer IZI
GLP Test Facility
more info
© Fraunhofer IZI
S3 safety laboratory
more info
© Fraunhofer IZI
Fraunhofer Institute for Cell Therapy and Immunology IZI